| Product Code: ETC088666 | Publication Date: Jun 2021 | Updated Date: Sep 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Singapore radiopharmaceutical market is poised for growth as healthcare and medical research activities continue to advance. Radiopharmaceuticals play a crucial role in nuclear medicine, diagnostics, and cancer treatment. Singapore commitment to biomedical research and healthcare excellence is expected to drive the demand for radiopharmaceuticals, making it a significant player in the regional market.
The Singapore Radiopharmaceutical market is poised for growth due to advancements in healthcare technology and the aging population. Radiopharmaceuticals are used in medical imaging and therapy, particularly in diagnosing and treating cancer and cardiovascular diseases. As Singapore healthcare sector continues to expand and invest in cutting-edge medical equipment and therapies, the demand for radiopharmaceuticals is expected to rise. Research and development in nuclear medicine are also contributing to the market`s evolution.
The Singapore radiopharmaceutical market faces unique challenges due to its role in medical imaging and nuclear medicine. Regulatory compliance and safety standards are paramount, given the radioactive nature of these products. Ensuring a consistent supply of radiopharmaceuticals, which often have short half-lives, requires sophisticated infrastructure and logistics. The high costs associated with producing and transporting radiopharmaceuticals can be a barrier to access for some medical facilities. Balancing the need for cutting-edge diagnostic and therapeutic tools with cost-effectiveness and safety remains a significant challenge.
The radiopharmaceutical market in Singapore faced unique challenges during the COVID-19 pandemic. As healthcare resources were redirected to combat the virus, elective medical procedures, including certain diagnostic tests using radiopharmaceuticals, were postponed. This resulted in a temporary decline in demand. However, as the healthcare system adapts to the new normal, the radiopharmaceutical market is poised for recovery. The market`s outlook remains optimistic, driven by advancements in medical imaging and the aging population`s increasing healthcare needs.
The Singapore Radiopharmaceutical market is experiencing growth due to advancements in medical diagnostics and treatment. Major players in this sector include GE Healthcare, Siemens Healthineers, and Cardinal Health, Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Radiopharmaceutical Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Radiopharmaceutical Market - Industry Life Cycle |
3.4 Singapore Radiopharmaceutical Market - Porter's Five Forces |
3.5 Singapore Radiopharmaceutical Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Singapore Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Singapore Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Singapore Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Singapore Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Singapore Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine diagnostics and treatments |
4.2.2 Growing investments in healthcare infrastructure and advanced medical technologies |
4.2.3 Rising awareness about the benefits of nuclear medicine in disease diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with radiopharmaceutical production and acquisition |
4.3.2 Regulatory challenges and stringent approval processes for radiopharmaceutical products |
5 Singapore Radiopharmaceutical Market Trends |
6 Singapore Radiopharmaceutical Market, By Types |
6.1 Singapore Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Singapore Radiopharmaceutical Market Revenues & Volume, By Types, 2021-2031F |
6.1.3 Singapore Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.4 Singapore Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.2 Singapore Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Singapore Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.2.3 Singapore Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2021-2031F |
6.3 Singapore Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Singapore Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 Singapore Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
6.4 Singapore Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Singapore Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2021-2031F |
6.4.3 Singapore Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2021-2031F |
6.5 Singapore Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Singapore Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.3 Singapore Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.5.4 Singapore Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2021-2031F |
6.5.5 Singapore Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2021-2031F |
6.5.6 Singapore Radiopharmaceutical Market Revenues & Volume, By Others, 2021-2031F |
7 Singapore Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Singapore Radiopharmaceutical Market Export to Major Countries |
7.2 Singapore Radiopharmaceutical Market Imports from Major Countries |
8 Singapore Radiopharmaceutical Market Key Performance Indicators |
8.1 Number of new nuclear medicine facilities or departments established |
8.2 Adoption rate of advanced radiopharmaceutical imaging technologies |
8.3 Number of research studies or clinical trials utilizing radiopharmaceuticals |
8.4 Patient satisfaction levels with nuclear medicine services |
8.5 Percentage of healthcare professionals trained in nuclear medicine techniques |
9 Singapore Radiopharmaceutical Market - Opportunity Assessment |
9.1 Singapore Radiopharmaceutical Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Singapore Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Singapore Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Singapore Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Singapore Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Singapore Radiopharmaceutical Market - Competitive Landscape |
10.1 Singapore Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Singapore Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |